Tumor hypoxia is associated with poor patient survival and is a characteristic of glioblastoma. Notch signaling is implicated in maintaining glioma stem-like cells (GSCs) within the hypoxic niche, although the molecular mechanisms linking hypoxia to Notch activation have not been clearly delineated. Here we show that Vasorin is a critical link between hypoxia and Notch signaling in GSCs. Vasorin is preferentially induced in GSCs by a HIF1α/STAT3 co-activator complex and stabilizes Notch1 protein at the cell membrane. This interaction prevents Numb from binding Notch1, rescuing it from Numb-mediated lysosomal degradation. Thus, Vasorin acts as a switch to augment Notch signaling under hypoxic conditions. Vasorin promotes tumor growth and reduces survival in mouse models of glioblastoma, and its expression correlates with increased aggression of human gliomas. These findings provide mechanistic insights into how hypoxia promotes Notch signaling in glioma and identify Vasorin as a potential therapeutic target.
Pubmed ID: 29198941 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A commercial graphing software company that offers scientific software for statistical analyses, curve fitting and data analysis. It offers four programs: Prism, InStat, StatMate and QuickCalcs.
View all literature mentionsPortal to interactively visualize genomic data. Provides reference sequences and working draft assemblies for collection of genomes and access to ENCODE and Neanderthal projects. Includes collection of vertebrate and model organism assemblies and annotations, along with suite of tools for viewing, analyzing and downloading data.
View all literature mentionsThis unknown targets Notch Isoform
View all literature mentionsThis monoclonal targets Stat3
View all literature mentionsThis monoclonal targets SOX-2 clone 10H9.1
View all literature mentionsThis monoclonal targets CD63
View all literature mentionsThis polyclonal targets Vasorin (C-12)
View all literature mentionsThis monoclonal targets Human Vasorin
View all literature mentionsThis polyclonal targets SOX2
View all literature mentionsThis monoclonal targets Phospho-Stat3 (Tyr705)
View all literature mentionsThis monoclonal targets Numb
View all literature mentionsThis monoclonal targets ND
View all literature mentionsThis monoclonal targets NOTCH1
View all literature mentionsThis monoclonal targets LC3B (D11) XP Rabbit mAb
View all literature mentionsThis monoclonal targets LC3A (D50G8) XP Rabbit mAb
View all literature mentionsThis monoclonal targets Mouse LAMP1/CD107a MAb (Clone 747203)
View all literature mentionsThis monoclonal targets HIF-2alpha (D9E3) Rabbit mAb
View all literature mentionsThis polyclonal targets Hes1 antibody
View all literature mentionsThis recombinant monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis monoclonal targets Cleaved PARP (Asp214)
View all literature mentionsThis monoclonal targets Cleaved Caspase-8 (Asp387)
View all literature mentionsThis monoclonal targets Human CD44v6
View all literature mentionsThis monoclonal targets CD133/1 (AC133)
View all literature mentionsThis monoclonal targets CA9 (D47G3) Rabbit mAb
View all literature mentionsThis monoclonal targets Stat3
View all literature mentionsThis unknown targets Notch Isoform
View all literature mentions